Arrowhead Pharmaceuticals (ARWR)
Nasdaq • ARWR • US04280A1007
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 8.9% of free float sold short, 5.9 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
Market Cap
6.92b USD | # 2048 in US
Volume
1.85m shares | 130.72m USD
Shares Outstanding
141.25m
Free Float Shares
86.69% | 122.45m
